Nano-X Imaging Ltd Experiences 2.22% Increase in Premarket Trading.
February 21, 2023
Trending News ☀️
NANO-X ($NASDAQ:NNOX): Nano-X Imaging Ltd has recently experienced a growth of 2.22% in its premarket trading. This increase is evidence of the company’s continuing success in providing innovative solutions to medical imaging technologies. Nano-X is a leader in the field of Neutron Emission Tomography (NET), which offers greater precision and accuracy in medical diagnosis and treatment. The company has recently launched a new range of products, including X-Ray generators and detectors, which are revolutionizing the way medical imaging is conducted.
Nano-X Imaging Ltd’s success in premarket trading, as well as its innovative products, demonstrates the company’s commitment to making medical imaging more efficient and reliable. As the company continues to achieve milestones in its mission to become a leader in NET and X-Ray imaging solutions, Nano-X Imaging Ltd can look forward to further increases in premarket trading.
Share Price
Media sentiment towards the company has mostly been positive at this time. On Friday, the stock opened at $8.0 and closed at $7.9, a decrease of 2.7% from its last closing price of 8.1. This surge in premarket trading activity is seen by many investors as a sign of potential future success for Nano-X Imaging Ltd. As of now, the company is experiencing increased interest from investors and is likely to see further positive results in the future. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Nano-x Imaging. More…
| Total Revenues | Net Income | Net Margin |
| 7.75 | -82.44 | -1025.8% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Nano-x Imaging. More…
| Operations | Investing | Financing |
| -49.83 | 10.99 | 1.67 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Nano-x Imaging. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 305.69 | 57.85 | 4.74 |
Key Ratios Snapshot
Some of the financial key ratios for Nano-x Imaging are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| – | – | -1075.8% |
| FCF Margin | ROE | ROA |
| -814.5% | -20.4% | -17.0% |
Analysis
At GoodWhale, we’ve conducted an in-depth analysis of NANO-X IMAGING‘s wellbeing. After thoroughly examining a variety of financial metrics, our Risk Rating brought NANO-X IMAGING’s score to a high risk level. During our review, we noticed 2 potential risk warnings in the cashflow statement and financial journal. If you’re interested in learning more about these warnings and mitigating the risk associated with investing in NANO-X IMAGING, then we encourage you to register on our website at goodwhale.com. Our comprehensive review provides comprehensive insights that can help you protect your investments and make informed decisions about companies you’re interested in investing in. More…
Peers
The company’s products include the Nano X Ray System, a portable x-ray system that uses nanotechnology to generate high-resolution images; and the Nano X CT System, a nanotechnology-based computed tomography system that produces 3D images of the human body. Nano X Imaging’s competitors include Japan Vietnam Medical Instrument JSC, Medicalgorithmics SA, and EMvision Medical Devices Ltd.
– Japan Vietnam Medical Instrument JSC ($HOSE:JVC)
Vietnam Medical Instrument JSC is a medical equipment company located in Vietnam. As of 2022, the company has a market capitalization of 320.63 billion VND. The company’s Return on Equity (ROE) for the same year is -2.94%.
Vietnam Medical Instrument JSC is engaged in the manufacture and sale of medical equipment and supplies. The company offers a wide range of products, including X-ray machines, ultrasound machines, medical beds, and surgical instruments. It also provides services, such as repairs and maintenance of medical equipment.
– Medicalgorithmics SA ($LTS:0QR8)
Algorithmics SA is a publicly traded company with a market capitalization of 61.71M as of 2022. The company’s return on equity is 1662.69%, meaning that it has generated a significant amount of shareholder value. Algorithmics SA is a provider of software and services for the financial services industry. The company’s products and services are used by banks, insurance companies, and other financial institutions to manage risk and compliance.
– EMvision Medical Devices Ltd ($ASX:EMV)
EMvision Medical Devices Ltd is a medical device company that develops and commercializes 3D and 4D medical imaging products. The company has a market cap of 131.68M as of 2022 and a Return on Equity of -43.39%. EMvision’s products are used for the diagnosis and treatment of various conditions, including cancer, cardiovascular disease, and neurological disorders. The company’s products are sold worldwide.
Summary
Nano-X Imaging Ltd saw an increase of 2.22% in pre-market trading, with a mostly positive sentiment from the media. For investors looking to invest in Nano-X Imaging, it’s important to note the company’s long-term financial performance and growth potential. Analyzing data such as market share, management and founder expertise, customer base and competitive advantages can help investors make informed decisions.
Furthermore, investors should be mindful of potential risks, such as macroeconomic and industry conditions and the company’s ability to deliver consistent returns. Ultimately, any good investor should understand the company they plan to invest in before making a commitment.
Related Posts
Recent Posts
